Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 8 results:
Author Title Type [ Year(Asc)]
Filters: Author is Garbe, E.  [Clear All Filters]
2010
F. Andersohn, Waring, M., and Garbe, E., “Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study”, Inflamm Bowel Dis, vol. 16, pp. 1387-92, 2010.
C. Renoux, Dell'Aniello, S., Garbe, E., and Suissa, S., “Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study”, Bmj, vol. 340, p. c2519, 2010.
F. Andersohn, Schade, R., Willich, S. N., and Garbe, E., “Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior”, Neurology, vol. 75, pp. 335-40, 2010.
2009
F. Andersohn, Schade, R., Suissa, S., and Garbe, E., “Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus”, Am J Psychiatry, vol. 166, pp. 591-8, 2009.
2008
C. Renoux, Dell'Aniello, S., Garbe, E., and Suissa, S., “Hormone replacement therapy use and the risk of stroke”, Maturitas, vol. 61, pp. 305-9, 2008.
2007
R. Schade, Andersohn, F., Suissa, S., Haverkamp, W., and Garbe, E., “Dopamine agonists and the risk of cardiac-valve regurgitation”, N Engl J Med, vol. 356, pp. 29-38, 2007.
2006
F. Andersohn, Schade, R., Suissa, S., and Garbe, E., “Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study”, Stroke, vol. 37, pp. 1725-30, 2006.
F. Andersohn, Suissa, S., and Garbe, E., “Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction”, Circulation, vol. 113, pp. 1950-7, 2006.
[Page last reviewed 6 April 2021]